annual EBITDA:
-$96.79M-$25.76M(-36.27%)Summary
- As of today (June 17, 2025), JANX annual EBITDA is -$96.79 million, with the most recent change of -$25.76 million (-36.27%) on December 31, 2024.
- During the last 3 years, JANX annual EBITDA has fallen by -$63.97 million (-194.94%).
- JANX annual EBITDA is now -2470.70% below its all-time high of -$3.77 million, reached on December 31, 2019.
Performance
JANX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$34.38M-$5.87M(-20.58%)Summary
- As of today (June 17, 2025), JANX quarterly EBITDA is -$34.38 million, with the most recent change of -$5.87 million (-20.58%) on March 31, 2025.
- Over the past year, JANX quarterly EBITDA has dropped by -$14.75 million (-75.14%).
- JANX quarterly EBITDA is now -2639.28% below its all-time high of -$1.25 million, reached on September 30, 2020.
Performance
JANX quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$111.54M-$14.75M(-15.24%)Summary
- As of today (June 17, 2025), JANX TTM EBITDA is -$111.54 million, with the most recent change of -$14.75 million (-15.24%) on March 31, 2025.
- Over the past year, JANX TTM EBITDA has dropped by -$40.71 million (-57.48%).
- JANX TTM EBITDA is now -8388.28% below its all-time high of -$1.31 million, reached on March 31, 2020.
Performance
JANX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
JANX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -36.3% | -75.1% | -57.5% |
| 3 y3 years | -194.9% | -155.4% | -153.5% |
| 5 y5 years | -2470.7% | -2516.3% | -8388.3% |
JANX EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -194.9% | at low | -158.2% | +2.7% | -153.5% | at low |
| 5 y | 5-year | -2470.7% | at low | -2639.3% | +2.7% | -8388.3% | at low |
| alltime | all time | -2470.7% | at low | -2639.3% | +2.7% | -8388.3% | at low |
JANX EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$34.38M(+20.6%) | -$111.54M(+15.2%) |
| Dec 2024 | -$96.79M(+36.3%) | -$28.51M(-19.3%) | -$96.79M(+15.4%) |
| Sep 2024 | - | -$35.33M(+165.3%) | -$83.88M(+31.3%) |
| Jun 2024 | - | -$13.32M(-32.2%) | -$63.86M(-9.8%) |
| Mar 2024 | - | -$19.63M(+25.8%) | -$70.83M(-0.3%) |
| Dec 2023 | -$71.02M(+7.2%) | -$15.61M(+1.9%) | -$71.02M(-3.1%) |
| Sep 2023 | - | -$15.31M(-24.5%) | -$73.28M(-3.2%) |
| Jun 2023 | - | -$20.28M(+2.3%) | -$75.74M(+4.3%) |
| Mar 2023 | - | -$19.83M(+11.0%) | -$72.62M(+9.6%) |
| Dec 2022 | -$66.25M | -$17.86M(+0.5%) | -$66.25M(+7.2%) |
| Sep 2022 | - | -$17.77M(+3.6%) | -$61.81M(+12.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$17.15M(+27.4%) | -$54.92M(+24.8%) |
| Mar 2022 | - | -$13.46M(+0.3%) | -$44.00M(+34.1%) |
| Dec 2021 | -$32.82M(+399.9%) | -$13.43M(+23.4%) | -$32.82M(+56.0%) |
| Sep 2021 | - | -$10.88M(+74.3%) | -$21.04M(+84.3%) |
| Jun 2021 | - | -$6.24M(+174.2%) | -$11.41M(+51.7%) |
| Mar 2021 | - | -$2.27M(+38.2%) | -$7.53M(+14.6%) |
| Dec 2020 | -$6.57M(+74.4%) | -$1.65M(+31.2%) | -$6.57M(+33.5%) |
| Sep 2020 | - | -$1.25M(-46.6%) | -$4.92M(+34.3%) |
| Jun 2020 | - | -$2.35M(+78.8%) | -$3.66M(+178.8%) |
| Mar 2020 | - | -$1.31M | -$1.31M |
| Dec 2019 | -$3.77M | - | - |
FAQ
- What is Janux Therapeutics annual EBITDA?
- What is the all time high annual EBITDA for Janux Therapeutics?
- What is Janux Therapeutics annual EBITDA year-on-year change?
- What is Janux Therapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for Janux Therapeutics?
- What is Janux Therapeutics quarterly EBITDA year-on-year change?
- What is Janux Therapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for Janux Therapeutics?
- What is Janux Therapeutics TTM EBITDA year-on-year change?
What is Janux Therapeutics annual EBITDA?
The current annual EBITDA of JANX is -$96.79M
What is the all time high annual EBITDA for Janux Therapeutics?
Janux Therapeutics all-time high annual EBITDA is -$3.77M
What is Janux Therapeutics annual EBITDA year-on-year change?
Over the past year, JANX annual EBITDA has changed by -$25.76M (-36.27%)
What is Janux Therapeutics quarterly EBITDA?
The current quarterly EBITDA of JANX is -$34.38M
What is the all time high quarterly EBITDA for Janux Therapeutics?
Janux Therapeutics all-time high quarterly EBITDA is -$1.25M
What is Janux Therapeutics quarterly EBITDA year-on-year change?
Over the past year, JANX quarterly EBITDA has changed by -$14.75M (-75.14%)
What is Janux Therapeutics TTM EBITDA?
The current TTM EBITDA of JANX is -$111.54M
What is the all time high TTM EBITDA for Janux Therapeutics?
Janux Therapeutics all-time high TTM EBITDA is -$1.31M
What is Janux Therapeutics TTM EBITDA year-on-year change?
Over the past year, JANX TTM EBITDA has changed by -$40.71M (-57.48%)